Shenzhen BioX Medical Co., Ltd. stands as a vanguard in the global precision medicine landscape. As a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment, we bridge the gap between complex biotechnology and practical clinical applications.
Established in 2017 and headquartered in Shenzhen—China’s premier hub for biotechnology innovation—we operate a world-class manufacturing facility exceeding 9,000 square meters. Our multidisciplinary workforce of over 200 elite employees is dedicated to the R&D, production, and supply of cutting-edge diagnostic technologies for hospitals, research institutions, and biotech firms worldwide.
Founded in Shenzhen Innovation Center
Advanced Production Facility
Specialized Technical Personnel
Serving 60+ Countries & Regions
The paradigm shift from "one-size-fits-all" medicine to Precision Healthcare is driving an unprecedented demand for high-fidelity diagnostic tools. The global molecular diagnostics market is projected to expand significantly, fueled by advancements in genomics, oncology, and infectious disease management.
Integration of Next-Generation Sequencing (NGS) and High-Sensitivity PCR into routine clinical workflows is no longer optional—it is a standard for modern oncology and rare disease diagnosis.
The rise of Point-of-Care Testing (POCT) requires compact, portable, yet powerful diagnostic systems like our 8-well portable PCR units to ensure rapid response in localized environments.
Modern precision medicine tools now incorporate AI-driven imaging and automated reporting, reducing human error and increasing the throughput of busy clinical labs.
Our commitment to Information Gain in the diagnostic field is reflected in our robust product portfolio which includes molecular diagnostic analysis systems, nucleic acid testing platforms, and biomarker analysis equipment. We focus on three core pillars:
We are currently developing next-generation multi-omic integration platforms that will combine proteomic and genomic data in a single automated workflow. Our R&D team is focusing on AI-enhanced pathogen identification and cloud-based diagnostic synchronization, allowing labs across the globe to share data and insights in real-time, conforming to the evolving standards of global healthcare.
Compliance with CE, ISO 13485, and regional FDA requirements. We ensure that every piece of equipment meets the rigorous safety and efficacy standards of the target market.
We provide multidisciplinary support including on-site training for laboratory specialists and engineers to ensure operational reliability from day one.
Our Shenzhen headquarters acts as a logistics nexus, ensuring stable delivery of consumables and spare parts to Europe, North America, and the Asia-Pacific.
High-throughput extraction and automated PCR detection for rapid patient screening and personalized treatment plans in oncology and infectious disease.
Our Portable 8-Well PCR systems are utilized in remote farms for early detection of animal diseases, preventing large-scale economic loss.
Gel imaging and documentation systems providing high-resolution data for genomic research and DNA/RNA electrophoresis studies.
Rapid deployment of portable fluorescence analyzers in community clinics for immediate diagnostic results during health crises.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, Shenzhen BioX Medical Co., Ltd. continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Our global footprint serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. Committed to advancing modern laboratory technologies, BioX Medical focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, we strive to contribute to the global evolution of molecular diagnostics and laboratory medicine.
BioX Medical
